Cowen Prime Advisors’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $3.05M | Buy |
605,682
+3,500
| +0.6% | +$17.6K | 1.05% | 23 |
|
2023
Q1 | $2.05M | Sell |
602,182
-4,100
| -0.7% | -$13.9K | 0.82% | 30 |
|
2022
Q4 | $1.42M | Buy |
606,282
+338,517
| +126% | +$792K | 0.58% | 37 |
|
2022
Q3 | $1.2M | Hold |
267,765
| – | – | 0.69% | 31 |
|
2022
Q2 | $1.57M | Buy |
267,765
+13,906
| +5% | +$81.5K | 0.89% | 32 |
|
2022
Q1 | $1.66M | Buy |
253,859
+2,100
| +0.8% | +$13.7K | 0.7% | 34 |
|
2021
Q4 | $3.23M | Hold |
251,759
| – | – | 1.1% | 22 |
|
2021
Q3 | $3.49M | Buy |
251,759
+2,800
| +1% | +$38.8K | 1.3% | 18 |
|
2021
Q2 | $2.57M | Hold |
248,959
| – | – | 0.93% | 29 |
|
2021
Q1 | $2.41M | Buy |
248,959
+13,000
| +6% | +$126K | 0.91% | 30 |
|
2020
Q4 | $1.7M | Sell |
235,959
-2,010
| -0.8% | -$14.5K | 0.75% | 28 |
|
2020
Q3 | $1.12M | Sell |
237,969
-29,796
| -11% | -$140K | 0.55% | 38 |
|
2020
Q2 | $1.57M | Buy |
267,765
+8,051
| +3% | +$47.2K | 0.89% | 32 |
|
2020
Q1 | $932K | Sell |
259,714
-25,700
| -9% | -$92.2K | 0.57% | 40 |
|
2019
Q4 | $2.42M | Buy |
285,414
+11,509
| +4% | +$97.4K | 1.1% | 22 |
|
2019
Q3 | $1.85M | Buy |
273,905
+2,300
| +0.8% | +$15.6K | 0.96% | 28 |
|
2019
Q2 | $1.83M | Sell |
271,605
-19,600
| -7% | -$132K | 0.88% | 30 |
|
2019
Q1 | $1.84M | Sell |
291,205
-39,345
| -12% | -$248K | 0.95% | 30 |
|
2018
Q4 | $2.14M | Buy |
330,550
+24,845
| +8% | +$161K | 1.29% | 23 |
|
2018
Q3 | $2.17M | Sell |
305,705
-42,388
| -12% | -$301K | 1.01% | 33 |
|
2018
Q2 | $1.51M | Buy |
348,093
+32,636
| +10% | +$142K | 0.75% | 39 |
|
2018
Q1 | $937K | Buy |
315,457
+20,416
| +7% | +$60.6K | 0.52% | 49 |
|
2017
Q4 | $767K | Buy |
295,041
+120,871
| +69% | +$314K | 0.37% | 52 |
|
2017
Q3 | $589K | Sell |
174,170
-75,470
| -30% | -$255K | 0.28% | 55 |
|
2017
Q2 | $617K | Buy |
249,640
+167,862
| +205% | +$415K | 0.28% | 52 |
|
2017
Q1 | $218K | Buy |
81,778
+31,378
| +62% | +$83.6K | 0.11% | 75 |
|
2016
Q4 | $181K | Buy |
50,400
+1,300
| +3% | +$4.67K | 0.1% | 83 |
|
2016
Q3 | $256K | Buy |
49,100
+40,000
| +440% | +$209K | 0.12% | 101 |
|
2016
Q2 | $15K | Buy |
+9,100
| New | +$15K | 0.01% | 182 |
|